OR WAIT 15 SECS
An international research team may have found a way to block a second wave of death that can result from pneumonia treatment.
Antibiotics are effective at killing pneumococcus the cause of about 50 percent of pneumonias but as it dies the bacterium releases potentially lethal toxins.
Adding an agonist that mimics the action of growth hormone-releasing hormone which ultimately enables growth may stop that second wave, according to research published in the Proceedings of the National Academy of Sciences.
"You have to take antibiotics, if you don't, the bugs will grow and you most likely will die anyway," says Dr. Rudolf Lucas, vascular biologist at the Medical College of Georgia at Georgia Health Sciences University.
Problems start when a bacterium that causes pneumonia, in this case pneumococcus, is inhaled. Symptoms include mucus buildup, cough, fever, chills and shortness of breath. Antibiotics are the front line treatment to kill the infection.
An unfortunate result of bacterium death is release of pneumolysin, a toxin that can trigger formation of holes in the walls of the millions of tiny air sacs and blood vessels in the lungs. The result is that fluid, blood and other products find their way into air sacs that were intended for oxygen exchange.
"It's like making a hole in a bucket," sayhs Lucas. He and Dr. Andrew V. Schally, the Distinguished Leonard M. Miller Professor of Pathology & Professor of Hematology/Oncology at the University of Miami Miller School of Medicine, are co-corresponding authors on the study.
Pneumolysin naturally binds to cholesterol, a component of all cell membranes including cells lining the air sacs, or alveoli. Once attached to the membrane, the toxin produces complexes that make holes in the membranes of the air sacs before escaping to do similar damage to nearby capillaries. While the close proximity of capillaries normally enables air sacs to replenish blood with oxygen and to remove carbon dioxide, the now open exchange enables fluid and cells from the capillaries to penetrate air sacs as well as the space in between them. To make matters worse, the toxin also blocks a protective sodium uptake system in the lungs that can help remove fluids. Within a few days, the patient is back in jeopardy.
"These patients are being treated with an antibiotic and aggressive intensive care support and they (can) still die," Lucas says.